Paragon Gene
Paragon Bioservices develops and commercializes oncology immunotherapies for the treatment of cancer.
Business Model:
Revenue: $101M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Paragon Gene Information
Paragon Gene was acquired by
Catalent Pharma Solutions.
The acquisition happend on 2019-04-14.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 801 West Baltimore Street
City: Baltimore
State: MD
Zip: 21201
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$5M
Raised Total:$20M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Paragon Bioservices develops and commercializes oncology immunotherapies for the treatment of cancer.
Contact Phone:
+18005456569
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2015 | Series A | $2M | 10/2014 | Series A | 2 | $13M |
Camden Partners NewSpring Camden Partners NewSpring Camden Partners NewSpring Camden Partners NewSpring |
5/2017 | Debt | $2.4M | 10/2014 | Series A | $13.5M |
NewSpring Capital Camden Partners |
8/2018 | Venture Round | $5M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
